The FDA has issued a CRL to Biohaven regarding the NDA for troriluzole for the treatment of adults with spinocerebellar ataxia.

William Blair analyst Myles Minter downgraded Biohaven (BHVN) to Market Perform from Outperform. The announcement of a CRL for troriluzole in spinocerebellar ataxia halts not only a near-term source ...

・Biohaven was seeking approval for its drug Vyglxia in the treatment of Spinocerebellar ataxia. ・The company is in the process of formally requesting a meeting as soon as possible to determine the ...

You don’t need to buy state-of-the-art “super shoes” for your daily walk or run. Your walking shoes should be comfortable, said Benno Nigg, a professor emeritus of kinesiology at the University of ...

Looking for a comfortable walking shoe but don’t want to pay those outrageous prices to get one? Amazon has a deal on this NORTIV 8 walking shoe that wearers have compared to other popular brands. The ...

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today announced the poster ...

Sunlight filters through swaying trees, starlings flit between neat hedges and a man trots after an errant golden retriever, which is making a beeline for the reflecting pool. It’s difficult to ...

We remember on Sukkot that despite our considerable human ingenuity and skill, we remain dependent on God – not only for the technology itself but for help when our knowledge and tools fall short.

All content © 2025 Alzheimer's Society. Alzheimer's Society is a registered charity in England and Wales (296645) and the Isle of Man (1128). A company limited by ...